ASGE Postgraduate Course at ACG 2022: Expanding the Scope of Fundamental and Advanced Endoscopy (On-Demand) | October 2022-NEJM: Nordic-European Initiative on Colorectal Cancer (NordICC) trial report: An ASGE Update and Response

NEJM: Nordic-European Initiative on Colorectal Cancer (NordICC) trial report: An ASGE Update and Response

Video Transcription

Video Summary

In this video, ASGE president Brett Peterson discusses the Nordic trial on screening colonoscopy. The trial, published in the New England Journal of Medicine, showed that screening colonoscopy did not decrease colorectal cancer mortality at 10 years. However, Peterson highlights several concerns with the study, including low uptake of screening, early analysis at 10 years, and potential bias in the intention to screen analysis. He also compares the Nordic trial with a recent pooled sigmoidoscopy study that showed a reduction in colorectal cancer mortality after 10 years. Peterson emphasizes that colonoscopy remains an accurate method for detecting and treating colorectal neoplasia and recommends continuing with sequential offerings for screening. The ASGE and other organizations have cautioned against changing current screening practices based on this study. The video is available on the ASGE website.

Asset Subtitle

Bret Petersen, MD, MASGE

Keywords

ASGE president

Nordic trial

screening colonoscopy

colorectal cancer mortality

New England Journal of Medicine